LU78024A1 - - Google Patents

Info

Publication number
LU78024A1
LU78024A1 LU78024A LU78024A LU78024A1 LU 78024 A1 LU78024 A1 LU 78024A1 LU 78024 A LU78024 A LU 78024A LU 78024 A LU78024 A LU 78024A LU 78024 A1 LU78024 A1 LU 78024A1
Authority
LU
Luxembourg
Application number
LU78024A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU78024A1 publication Critical patent/LU78024A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/28—Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
LU78024A 1976-08-30 1977-08-25 LU78024A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT640576A AT350726B (de) 1976-08-30 1976-08-30 Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma

Publications (1)

Publication Number Publication Date
LU78024A1 true LU78024A1 (en:Method) 1978-01-11

Family

ID=3585985

Family Applications (1)

Application Number Title Priority Date Filing Date
LU78024A LU78024A1 (en:Method) 1976-08-30 1977-08-25

Country Status (17)

Country Link
US (1) US4160025A (en:Method)
AR (1) AR213861A1 (en:Method)
AT (1) AT350726B (en:Method)
BE (1) BE858031A (en:Method)
CA (1) CA1079191A (en:Method)
CH (1) CH635747A5 (en:Method)
DE (1) DE2734821C3 (en:Method)
DK (1) DK151932C (en:Method)
ES (1) ES461918A1 (en:Method)
FI (1) FI57421C (en:Method)
FR (1) FR2362633A1 (en:Method)
GB (1) GB1554051A (en:Method)
HU (1) HU180816B (en:Method)
LU (1) LU78024A1 (en:Method)
NL (1) NL170922C (en:Method)
NO (1) NO148142C (en:Method)
SE (1) SE443511B (en:Method)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
WO1981002105A1 (en) * 1980-01-28 1981-08-06 Baxter Travenol Lab Therapeutic compositions & methods for manufacture and use
US4287180A (en) * 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
EP0035204B2 (en) * 1980-03-05 1991-05-22 Miles Inc. Pasteurized therapeutically active protein compositions
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
US4361510A (en) * 1980-05-27 1982-11-30 Cutter Laboratories, Inc. Blood coagulation promoting product
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
DE3172210D1 (en) * 1980-05-27 1985-10-17 Miles Lab Blood coagulation promoting product and process of preparing same
US4391746A (en) * 1980-05-27 1983-07-05 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
US4479938A (en) * 1981-06-25 1984-10-30 Baxter Travenol Laboratories, Inc. Therapeutic composition containing factor VIIa
US4382083A (en) * 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
JPS5866054A (ja) * 1981-10-14 1983-04-20 Sekisui Chem Co Ltd 血液検査用容器
JPS58105064A (ja) * 1981-12-17 1983-06-22 Sekisui Chem Co Ltd 血液凝固促進剤
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
CA1330302C (en) * 1988-01-18 1994-06-21 Miroslav Rybak Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
WO1994013329A1 (de) * 1992-12-16 1994-06-23 Immuno Aktiengesellschaft Verfahren zur herstellung eines virussicheren biologischen präparates
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
US5677162A (en) * 1995-05-01 1997-10-14 New York Blood Center, Inc. Method for activating prothrombin to thrombin
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
CZ81997A3 (en) * 1996-03-20 1997-10-15 Immuno Ag Pharmaceutical preparation for treating disorders connected with blood clotting, process of its preparation and use
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
RS20050051A (sr) * 2002-07-23 2007-06-04 Bio-Products & Bio Engineering Ag., Farmaceutski aktivni sastojak preparata i medikamenata koji sadrže trombin ili imaju mogućnost stvaranja trombina
AU2003246448A1 (en) * 2002-07-23 2004-02-16 Bio-Products And Bio-Engineering Aktiengesellschaft Pharmaceutically active substance preparations and drugs that are capable of generating thrombin and/or that contain thrombin
EP2305289A1 (en) 2009-09-16 2011-04-06 Bio-Products & Bio-Engineering Aktiengesellschaft Medicinal products for the treatment of blood coagulation disorders
IS2809B (is) * 2011-03-08 2012-10-15 Haskoli Islands Blóðstorkumæling
RU2648517C1 (ru) * 2017-06-23 2018-03-26 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения Российской Федерации (ФГБУ ГНЦ Минздрава России) Способ получения лиофилизированного препарата активированного протромбинового комплекса, обладающего фактор viii-шунтирующей активностью
JP2022041059A (ja) * 2020-08-31 2022-03-11 シスメックス株式会社 検量線の表示方法および分析装置
WO2024012853A1 (de) 2022-07-12 2024-01-18 Biomedizinische Forschung & Bio-Produkte AG Arzneimittel zur förderung der hämostase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2262520C3 (de) * 1972-12-20 1987-02-12 Miles Laboratories, Inc., Elkhart, Ind. Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma
DE2459291C3 (de) * 1974-12-14 1981-06-04 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen
US3998946A (en) * 1975-04-23 1976-12-21 The Regents Of The University Of Minnesota Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same
DD121793A1 (en:Method) * 1975-07-17 1976-08-20
US4027013A (en) * 1976-01-22 1977-05-31 William L. Wilson Clottable fibrinogen free factor VIII and albumin product and process

Also Published As

Publication number Publication date
GB1554051A (en) 1979-10-17
NL170922B (nl) 1982-08-16
SE7707992L (sv) 1978-03-01
FI772408A7 (fi) 1978-03-01
FR2362633B1 (en:Method) 1981-06-12
DK151932C (da) 1988-06-20
FI57421C (fi) 1980-08-11
HU180816B (en) 1983-04-29
FI57421B (fi) 1980-04-30
DK151932B (da) 1988-01-18
DK384577A (da) 1978-03-01
NO148142B (no) 1983-05-09
AT350726B (de) 1979-06-11
BE858031A (fr) 1977-12-16
NO148142C (no) 1983-08-17
ES461918A1 (es) 1978-12-16
NL7708872A (nl) 1978-03-02
DE2734821B2 (de) 1980-11-06
ATA640576A (de) 1978-11-15
CA1079191A (en) 1980-06-10
DE2734821A1 (de) 1978-03-02
NL170922C (nl) 1983-01-17
DE2734821C3 (de) 1985-03-14
FR2362633A1 (fr) 1978-03-24
NO772978L (no) 1978-03-01
AR213861A1 (es) 1979-03-30
US4160025A (en) 1979-07-03
CH635747A5 (de) 1983-04-29
SE443511B (sv) 1986-03-03

Similar Documents

Publication Publication Date Title
FR2362633B1 (en:Method)
DE2757725C3 (en:Method)
DE2710069B2 (en:Method)
DK221976A (en:Method)
DE2653191C3 (en:Method)
DE2612889C2 (en:Method)
JPS5351530U (en:Method)
DK182276A (en:Method)
CS175518B1 (en:Method)
DE7711806U1 (en:Method)
DD123115A1 (en:Method)
DD125533A1 (en:Method)
CH604437A5 (en:Method)
CH606618A5 (en:Method)
CH610960A5 (en:Method)
CH611751A5 (en:Method)
CH612326A5 (en:Method)
CH612393A5 (en:Method)
CH612620A5 (en:Method)
CH614678A5 (en:Method)
CH614957A5 (en:Method)
CH615021A5 (en:Method)
CH619583GA3 (en:Method)
CH602230A5 (en:Method)
CH601828A5 (en:Method)